By LEV FACHER @levfacher
SEPTEMBER 8, 2020
The group of nine companies includes Moderna, AstraZeneca, and the ongoing collaboration between Pfizer and BioNTech — three of the Covid-19 vaccine efforts that have advanced into late-stage clinical trials, and whose vaccine candidates are likely to be considered for emergency approvals in the coming months. Top executives at Merck, GlaxoSmithKline, Johnson & Johnson, Sanofi, and Novavax also signed the pledge.
SEPTEMBER 8, 2020
The group of nine companies includes Moderna, AstraZeneca, and the ongoing collaboration between Pfizer and BioNTech — three of the Covid-19 vaccine efforts that have advanced into late-stage clinical trials, and whose vaccine candidates are likely to be considered for emergency approvals in the coming months. Top executives at Merck, GlaxoSmithKline, Johnson & Johnson, Sanofi, and Novavax also signed the pledge.
Comment